Hot Hearts on Bone Scintigraphy Are Not All Amyloidosis: Hyperoxaluria-Associated Cardiomyopathy

Ya-Wen Wang1, Yan-Ting Xie2, Xiao-Xin Sun

  • 1From the Department of Nuclear Medicine, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing.

PubMed

Insights

Primary hyperoxaluria can cause a false positive 99m Tc-PYP scan in patients with infiltrative cardiomyopathy. This highlights the importance of considering non-amyloid causes of cardiac uptake in pyrophosphate imaging.

Area of Science:

  • Nephrology
  • Cardiology
  • Nuclear Medicine

Background:

  • End-stage renal disease (ESRD) patients may develop infiltrative cardiomyopathy.
  • 99m Tc-pyrophosphate (99m Tc-PYP) scintigraphy is used to detect cardiac amyloidosis.

Observation:

  • A 54-year-old woman with ESRD presented with infiltrative cardiomyopathy.
  • Echocardiography revealed infiltrative cardiomyopathy.
  • 99m Tc-PYP scintigraphy showed significant myocardial uptake.

Findings:

  • Genetic testing identified an AGXT gene mutation, confirming primary hyperoxaluria.
  • Myocardial uptake on 99m Tc-PYP scan was attributed to oxalate deposition in the heart.
  • This case demonstrates a false positive 99m Tc-PYP scan due to hyperoxaluria-associated cardiomyopathy.

Implications:

  • Primary hyperoxaluria should be considered in the differential diagnosis of myocardial uptake on 99m Tc-PYP scans.
  • This finding expands the understanding of conditions mimicking cardiac amyloidosis.
  • Awareness of non-amyloid etiologies can improve diagnostic accuracy in cardiomyopathy evaluations.